By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Detection today announced the completion of a $1.9 million Series B recapitalization round, which will be used to further advance its molecular diagnostic panel for methicillin-resistant Staphylococcus aureus and to develop panels for sepsis and gastrointestinal infections.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.